Abbvie

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated Abbvie logo

E_DEPRECATED Error in file �functions_general.php� at line 186: Function utf8_encode() is deprecated

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

Keywords:

Date	News
2020-02-11	AbbVie to Present at the SVB Leerink 9th Annual Global Healthcare Conference
2020-02-07	AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results
2020-02-05	RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis
2020-01-31	AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Wee...
2020-01-31	AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Chemotherapy-Free Combination Regimen for Patients with Previo...
2020-01-27	AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes
2020-01-27	AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep
2020-01-14	New Head-to-Head Phase 3 Data Show SKYRIZI™ (risankizumab) Superior to Cosentyx® (secukinumab) Across Primary and All Ra...
2020-01-14	New Head-to-Head Phase 3 Data Show Skyrizi™ (risankizumab) Superior to Cosentyx®* (secukinumab) Across Primary and All R...
2020-01-13	AbbVie to Host Fourth-Quarter and Full-Year 2019 Earnings Conference Call

Date

News

2020-02-11

AbbVie to Present at the SVB Leerink 9th Annual Global Healthcare Conference

2020-02-07

AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results

2020-02-05

RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis

2020-01-31

AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Wee...

2020-01-31

AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Chemotherapy-Free Combination Regimen for Patients with Previo...